 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||||||||| P013 (pertuzumab biosimilar) / CinnaGen, Perjeta (pertuzumab) / Roche
New P3 trial: Comparing Efficacy and Safety Between Pertuzumab (clinicaltrials.gov) - Jul 12, 2021
P3, N=214, Completed, Sponsor: Cinnagen